News

New Zeland. Pharmaceutical company fined for fraud

Wellington, 3 Feb (PL) The New Zealand Trade Commission today upheld the fine imposed on the pharmaceutical company Reckitt Benckiser, maker of Nurofen, a deceptive drug.

Risultati immagini per nurofen reckitt benckiserA court in the city of Auckland fined the company more than 785,000 $ for misleading consumers.

According to the Commission, Reckitt Benckiser admitted that between 2011 and 2015 he gave misleading information about the nature, characteristics and suitability of a range of Nurofen products.

The Nurofen line of pain relievers is marketed for migraines, back pain, menstrual disorders, and stress-induced headaches.

However, all were found to contain the same drug base, 342 milligrams of ibuprofen lysine.

The ruling follows an Australian court fined Reckitt Benckiser $ 4,400,000 in mid-December for misleading the consumer.

Risultati immagini per nurofen reckitt benckiserThe company was found guilty of misinforming the consumer, assuring that certain Nurofen painkillers would relieve a specific pain.

Prensa Latina – 03/02/2017

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Guarda anche
Close
Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco